Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 75 articles: HTML format Text format

Single Articles

February 2018
1. KIYOKUNI M, Kawashima C, Konishi M, Sakamaki K, et al
   Relationship between sleep-disordered breathing and renal dysfunction in acute coronary syndrome.
   J Cardiol. 2018;71:168-173.
   PubMed     Text format     Abstract available
   
   
   January 2018
2. MATSUMOTO I, Misaki A, Kurozumi M, Nanba T, et al
   Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
   J Cardiol. 2018;71:10-15.
   PubMed     Text format     Abstract available
   
   
   
3. IGARASHI T, Iwai-Takano M, Wakamatsu H, Haruta M, et al
   Assessment of deformation of the mitral valve complex during off-pump coronary artery bypass surgery using three-dimensional echocardiography in a porcine model.
   J Cardiol. 2018;71:93-100.
   PubMed     Text format     Abstract available
   
   
   
4. YODA S, Hori Y, Hayase M, Mineki T, et al
   Correlation between early revascularization and major cardiac events demonstrated by ischemic myocardium in Japanese patients with stable coronary artery disease.
   J Cardiol. 2018;71:44-51.
   PubMed     Text format     Abstract available
   
   
   
5. PARK KH, Jeong MH, Kim HK, Ahn TH, et al
   Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization.
   J Cardiol. 2018;71:36-43.
   PubMed     Text format     Abstract available
   
   
   October 2017
6. MIYOSHI T, Kawakami H, Seike F, Oshita A, et al
   Relationship between yellow plaque grade and tissue protrusion after stent implantation: A coronary angioscopy study.
   J Cardiol. 2017;70:342-345.
   PubMed     Text format     Abstract available
   
   
   September 2017
7. RHYOU HI, Park TH, Cho YR, Park K, et al
   Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI.
   J Cardiol. 2017 Sep 29. pii: S0914-5087(17)30236.
   PubMed     Text format     Abstract available
   
   
   
8. NISHIMOTO Y, Ueda Y, Sugihara R, Murakami A, et al
   Comparison of angioscopic findings among second-generation drug-eluting stents.
   J Cardiol. 2017;70:297-302.
   PubMed     Text format     Abstract available
   
   
   August 2017
9. ZENG RX, Li S, Zhang MZ, Li XL, et al
   Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
   J Cardiol. 2017;70:113-120.
   PubMed     Text format     Abstract available
   
   
   July 2017
10. YAMASHITA K, Fujita T, Hata H, Shimahara Y, et al
    Long-term outcome of isolated off-pump coronary artery bypass grafting in patients with coronary artery disease and mild to moderate aortic stenosis.
    J Cardiol. 2017;70:48-54.
    PubMed     Text format     Abstract available
    
    
    
11. FUJINO M, Ishihara M, Ogawa H, Nakao K, et al
    Impact of symptom presentation on in-hospital outcomes in patients with acute myocardial infarction.
    J Cardiol. 2017;70:29-34.
    PubMed     Text format     Abstract available
    
    
    
12. SATO T, Namba Y, Kashihara Y, Tanaka M, et al
    Clinical significance of platelet reactivity during prasugrel therapy in patients with acute myocardial infarction.
    J Cardiol. 2017;70:35-40.
    PubMed     Text format     Abstract available
    
    
    June 2017
13. KARJALAINEN PP, Nammas W
    Percutaneous revascularization of coronary chronic total occlusion: Toward a reappraisal of the available evidence.
    J Cardiol. 2017;69:799-807.
    PubMed     Text format     Abstract available
    
    
    
14. NAKACHI T, Kato S, Kirigaya H, Iinuma N, et al
    Prediction of functional recovery after percutaneous coronary revascularization for chronic total occlusion using late gadolinium enhanced magnetic resonance imaging.
    J Cardiol. 2017;69:836-842.
    PubMed     Text format     Abstract available
    
    
    
15. YAMAMOTO K, Sakakura K, Adachi Y, Taniguchi Y, et al
    Comparison of mid-term clinical outcomes between "complete full-metal jacket strategy" versus "incomplete full-metal jacket strategy" for diffuse right coronary artery stenosis with drug-eluting stents.
    J Cardiol. 2017;69:823-829.
    PubMed     Text format     Abstract available
    
    
    
16. GURSES KM, Ozmen F, Kocyigit D, Yersal N, et al
    Netrin-1 is associated with macrophage infiltration and polarization in human epicardial adipose tissue in coronary artery disease.
    J Cardiol. 2017;69:851-858.
    PubMed     Text format     Abstract available
    
    
    
17. UESHIMA D, Ashikaga T, Yoshikawa S, Sasaoka T, et al
    Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry.
    J Cardiol. 2017;69:815-822.
    PubMed     Text format     Abstract available
    
    
    
18. HASSAN A, Dohi T, Miyauchi K, Ogita M, et al
    Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
    J Cardiol. 2017;69:830-835.
    PubMed     Text format     Abstract available
    
    
    
19. YABE T, Toda M, Nakanishi R, Saito D, et al
    Clinical outcome of treatment with or without a final kissing balloon technique for bifurcation in-stent restenosis lesions.
    J Cardiol. 2017;69:808-814.
    PubMed     Text format     Abstract available
    
    
    May 2017
20. NISHI T, Ariyoshi N, Nakayama T, Fujimoto Y, et al
    Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients.
    J Cardiol. 2017;69:752-755.
    PubMed     Text format     Abstract available
    
    
    April 2017
21. TANAKA N, Pijls NH, Yamashita J, Kimura Y, et al
    Analysis of suboptimal stent deployment using intravascular ultrasound and coronary pressure pullback measurement.
    J Cardiol. 2017;69:613-618.
    PubMed     Text format     Abstract available
    
    
    
22. GONDO K, Ike A, Ogawa M, Shirai K, et al
    Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry.
    J Cardiol. 2017;69:652-659.
    PubMed     Text format     Abstract available
    
    
    
23. HUISMAN J, van der Heijden LC, Kok MM, Louwerenburg JH, et al
    Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.
    J Cardiol. 2017;69:660-665.
    PubMed     Text format     Abstract available
    
    
    
24. KASHIYAMA T, Otsuji S, Takiuchi S, Asano K, et al
    A multidirectional approach to risk assessment in patients with three-vessel coronary artery disease undergoing percutaneous intervention.
    J Cardiol. 2017;69:640-647.
    PubMed     Text format     Abstract available
    
    
    
25. HONDA Y, Yamawaki M, Mori S, Shirai S, et al
    Frequency and predictors of bleeding events after 2nd generation drug-eluting stent implantation differ depending on time after implantation.
    J Cardiol. 2017;69:632-639.
    PubMed     Text format     Abstract available
    
    
    March 2017
26. KAJIWARA M, Tanaka A, Kawasaki T, Nakao K, et al
    Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial.
    J Cardiol. 2017;69:511-517.
    PubMed     Text format     Abstract available
    
    
    February 2017
27. KUBO T, Ino Y, Matsuo Y, Shiono Y, et al
    Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: An optical coherence tomography study.
    J Cardiol. 2017;69:436-441.
    PubMed     Text format     Abstract available
    
    
    
28. SIM DS, Jeong MH, Ahn Y, Kim YJ, et al
    Manual thrombus aspiration during primary percutaneous coronary intervention: Impact of total ischemic time.
    J Cardiol. 2017;69:428-435.
    PubMed     Text format     Abstract available
    
    
    January 2017
29. MOUWS EM, Yaksh A, Knops P, Kik C, et al
    Early ventricular tachyarrhythmias after coronary artery bypass grafting surgery: Is it a real burden?
    J Cardiol. 2017 Jan 6. pii: S0914-5087(16)30342.
    PubMed     Text format     Abstract available
    
    
    
30. NUMASAWA Y, Kohsaka S, Ueda I, Miyata H, et al
    Incidence and predictors of bleeding complications after percutaneous coronary intervention.
    J Cardiol. 2017;69:272-279.
    PubMed     Text format     Abstract available
    
    
    
31. UCHIDA Y, Uchida Y, Shimoyama E, Hiruta N, et al
    Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery.
    J Cardiol. 2017;69:236-244.
    PubMed     Text format     Abstract available
    
    
    
32. PARK H, Kim HK, Jeong MH, Cho JY, et al
    Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
    J Cardiol. 2017;69:216-221.
    PubMed     Text format     Abstract available
    
    
    
33. FUIJKSCHOT WW, Groothuizen WE, Appelman Y, Radonic T, et al
    Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction.
    J Cardiol. 2017;69:394-400.
    PubMed     Text format     Abstract available
    
    
    
34. KUNIMURA A, Ishii H, Uetani T, Aoki T, et al
    Impact of Geriatric Nutritional Risk Index on cardiovascular outcomes in patients with stable coronary artery disease.
    J Cardiol. 2017;69:383-388.
    PubMed     Text format     Abstract available
    
    
    
35. KIM HK, Jeong MH, Ahn Y, Chae SC, et al
    Relationship between time to treatment and mortality among patients undergoing primary percutaneous coronary intervention according to Korea Acute Myocardial Infarction Registry.
    J Cardiol. 2017;69:377-382.
    PubMed     Text format     Abstract available
    
    
    
36. KURAMITSU S, Miyauchi K, Yokoi H, Suwa S, et al
    Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study.
    J Cardiol. 2017;69:369-376.
    PubMed     Text format     Abstract available
    
    
    
37. BASARABA JE, Barry AR
    Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: A meta-analysis.
    J Cardiol. 2017;69:353-358.
    PubMed     Text format     Abstract available
    
    
    
38. NISHINO M, Mori N, Takiuchi S, Shishikura D, et al
    Indications and outcomes of excimer laser coronary atherectomy: Efficacy and safety for thrombotic lesions-The ULTRAMAN registry.
    J Cardiol. 2017;69:314-319.
    PubMed     Text format     Abstract available
    
    
    
39. MAEZAWA H, Maeda A, Iso Y, Sakai T, et al
    The histological characteristics and virtual histology findings of the tissues obtained by a distal protection device during endovascular therapy for peripheral artery disease.
    J Cardiol. 2017;69:125-130.
    PubMed     Text format     Abstract available
    
    
    
40. NAGASHIMA Z, Tsukahara K, Uchida K, Hibi K, et al
    Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    J Cardiol. 2017;69:156-161.
    PubMed     Text format     Abstract available
    
    
    
41. AKASAKA T, Hokimoto S, Sueta D, Tabata N, et al
    Clinical outcomes of percutaneous coronary intervention for acute coronary syndrome between hospitals with and without onsite cardiac surgery backup.
    J Cardiol. 2017;69:103-109.
    PubMed     Text format     Abstract available
    
    
    July 2016
42. HOSHI T, Sato A, Nogami A, Gosho M, et al
    Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    J Cardiol. 2016 Jul 18. pii: S0914-5087(16)30134.
    PubMed     Text format     Abstract available
    
    
    April 2016
43. MIZUGUCHI Y, Hashimoto S, Yamada T, Taniguchi N, et al
    Percutaneous coronary intervention for nonagenarian patients with ST-segment elevation myocardial infarction: Experience of a single Japanese center.
    J Cardiol. 2016;67:331-4.
    PubMed     Text format     Abstract available
    
    
    
44. KIMURA K, Nakao K, Shibata Y, Sone T, et al
    Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction.
    J Cardiol. 2016;67:307-13.
    PubMed     Text format     Abstract available
    
    
    
45. SAKAMOTO T, Ogawa H, Nakao K, Hokimoto S, et al
    Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
    J Cardiol. 2016;67:371-7.
    PubMed     Text format     Abstract available
    
    
    March 2016
46. YEH YT, Wu YW
    Is insulin truly harmful in diabetic patients undergoing percutaneous coronary intervention?
    J Cardiol. 2016;67:303.
    PubMed     Text format    
    
    
    
47. KONISHI Y, Ashikaga T, Sasaoka T, Kurihara K, et al
    Comparison of outcomes after everolimus-eluting stent implantation in diabetic versus non-diabetic patients in the Tokyo-MD PCI study.
    J Cardiol. 2016;67:241-7.
    PubMed     Text format     Abstract available
    
    
    
48. SCHAAF MJ, Mewton N, Rioufol G, Angoulvant D, et al
    Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients.
    J Cardiol. 2016;67:248-53.
    PubMed     Text format     Abstract available
    
    
    February 2016
49. ANTONIC M, Lipovec R, Gregorcic F, Juric P, et al
    Perioperative ascorbic acid supplementation does not reduce the incidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients.
    J Cardiol. 2016 Feb 22. pii: S0914-5087(16)00021.
    PubMed     Text format     Abstract available
    
    
    
50. KAWABE M, Sato A, Hoshi T, Sakai S, et al
    Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
    J Cardiol. 2016;67:170-6.
    PubMed     Text format     Abstract available
    
    
    
51. ZARDI EM, Zardi DM, Chin D, Sonnino C, et al
    Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.
    J Cardiol. 2016;67:125-30.
    PubMed     Text format     Abstract available
    
    
    
52. TAKAYAMA T, Kimura K, Fukuzawa S, Hirayama H, et al
    Evaluation of the safety and efficacy of TY-51924 in patients with ST elevated acute myocardial infarction - Early phase II first in patient pilot study.
    J Cardiol. 2016;67:162-9.
    PubMed     Text format     Abstract available
    
    
    January 2016
53. JORGE E, Baptista R, Calisto J, Faria H, et al
    Optical coherence tomography of the pulmonary arteries: A systematic review.
    J Cardiol. 2016;67:6-14.
    PubMed     Text format     Abstract available
    
    
    
54. LANDES U, Bental T, Orvin K, Vaknin-Assa H, et al
    Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    J Cardiol. 2016;67:51-6.
    PubMed     Text format     Abstract available
    
    
    
55. ANDO M, Yamauchi H, Morota T, Taketani T, et al
    Long-term outcome after the original and simple modified technique of valve-sparing aortic root reimplantation in Marfan-based population, David V University of Tokyo modification.
    J Cardiol. 2016;67:86-91.
    PubMed     Text format     Abstract available
    
    
    
56. TABATA N, Hokimoto S, Akasaka T, Arima Y, et al
    Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.
    J Cardiol. 2016;67:104-9.
    PubMed     Text format     Abstract available
    
    
    November 2015
57. BALLI M, Tasolar H, Cetin M, Hatem E, et al
    Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    J Cardiol. 2015 Nov 14. pii: S0914-5087(15)00313.
    PubMed     Text format     Abstract available
    
    
    September 2015
58. SUJINO Y, Tanno J, Nakano S, Funada S, et al
    Impact of hypoalbuminemia, frailty, and body mass index on early prognosis in older patients (>/=85 years) with ST-elevation myocardial infarction.
    J Cardiol. 2015;66:263-8.
    PubMed     Text format     Abstract available
    
    
    August 2015
59. ARAKAWA K, Himeno H, Kirigaya J, Otomo F, et al
    Impact of n-3 polyunsaturated fatty acids in predicting ischemia/reperfusion injury and progression of myocardial damage after reperfusion in patients with ST-segment elevation acute myocardial infarction.
    J Cardiol. 2015;66:101-7.
    PubMed     Text format     Abstract available
    
    
    
60. LE PAGE S, Prunier F
    Remote ischemic conditioning: Current clinical perspectives.
    J Cardiol. 2015;66:91-6.
    PubMed     Text format     Abstract available
    
    
    
61. BREUCKMANN F, Hochadel M, Darius H, Giannitsis E, et al
    Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.
    J Cardiol. 2015;66:108-13.
    PubMed     Text format     Abstract available
    
    
    
62. TOMITA H, Higaki T, Kobayashi T, Fujii T, et al
    Stenting for curved lesions using a novel curved balloon: Preliminary experimental study.
    J Cardiol. 2015;66:120-4.
    PubMed     Text format     Abstract available
    
    
    
63. KURITA A, Takashima H, Ando H, Kumagai S, et al
    Effects of eicosapentaenoic acid on peri-procedural (type IVa) myocardial infarction following elective coronary stenting.
    J Cardiol. 2015;66:114-9.
    PubMed     Text format     Abstract available
    
    
    July 2015
64. OGITA M, Miyauchi K, Kasai T, Doi S, et al
    Impact of preprocedural high-sensitive C-reactive protein levels on long-term clinical outcomes of patients with stable coronary artery disease and chronic kidney disease who were treated with drug-eluting stents.
    J Cardiol. 2015;66:15-21.
    PubMed     Text format     Abstract available
    
    
    
65. PAN W, Zhao D, Zhang C, Li W, et al
    Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    J Cardiol. 2015;66:9-14.
    PubMed     Text format     Abstract available
    
    
    
66. MIZUNO A, Ohde S, Nishizaki Y, Komatsu Y, et al
    Additional value of the red blood cell distribution width to the Mehran risk score for predicting contrast-induced acute kidney injury in patients with ST-elevation acute myocardial infarction.
    J Cardiol. 2015;66:41-5.
    PubMed     Text format     Abstract available
    
    
    May 2015
67. BOUDOULAS KD, Wolfe B, Ravi Y, Lilly S, et al
    The aortic stenosis complex: aortic valve, atherosclerosis, aortopathy.
    J Cardiol. 2015;65:377-82.
    PubMed     Text format     Abstract available
    
    
    
68. IKE A, Shirai K, Nishikawa H, Iwata A, et al
    Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry.
    J Cardiol. 2015;65:390-6.
    PubMed     Text format     Abstract available
    
    
    April 2015
69. OTA S, Tanimoto T, Orii M, Hirata K, et al
    Association between hyperglycemia at admission and microvascular obstruction in patients with ST-segment elevation myocardial infarction.
    J Cardiol. 2015;65:272-7.
    PubMed     Text format     Abstract available
    
    
    
70. CHOI JH, Seo JM, Lee DH, Park K, et al
    Clinical utility of new bleeding criteria: a prospective study of evaluation for the Bleeding Academic Research Consortium definition of bleeding in patients undergoing percutaneous coronary intervention.
    J Cardiol. 2015;65:324-9.
    PubMed     Text format     Abstract available
    
    
    
71. CHEN BW, Wang ZG, Liu Q, Wang X, et al
    Combination of pulse wave velocity with clinical factors as a promising tool to predict major adverse cardiac events after percutaneous coronary intervention.
    J Cardiol. 2015;65:318-23.
    PubMed     Text format     Abstract available
    
    
    March 2015
72. ARASZKIEWICZ A, Grygier M, Pyda M, Rajewska J, et al
    Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial infarction.
    J Cardiol. 2015 Mar 28. pii: S0914-5087(15)00070.
    PubMed     Text format     Abstract available
    
    
    February 2015
73. NAGATA I, Ike A, Nishikawa H, Zhang B, et al
    Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
    J Cardiol. 2015;65:105-11.
    PubMed     Text format     Abstract available
    
    
    
74. ISHII H, Murohara T
    Can lipid profiles predict clinical outcomes in hemodialysis patients with ischemic heart disease?
    J Cardiol. 2015;65:87-8.
    PubMed     Text format    
    
    
    January 2015
75. OPOLSKI MP, Staruch AD, Kusmierczyk M, Witkowski A, et al
    Computed tomography angiography for prediction of atrial fibrillation after coronary artery bypass grafting: Proof of concept.
    J Cardiol. 2015 Jan 8. pii: S0914-5087(14)00359.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: